Many people with sleep apnea also have conditions like diabetes, high blood pressure, or metabolic issues that make weight loss especially difficult
Check for air bubbles and remove them if necessary
Nonalcoholic steatohepatitis is the Most rapidly increasing indication for liver transplantation in the United States
Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician
This decision was made because this review aims to provide a general overview of the current literature landscape and summarize the progress of research in this emerging area, rather than to conduct a formal meta-analysis or systematic review
What are some side effects of Mounjaro